Fig. 5
Comparison of treatment-free interval (days) between patients. A Early-stage tumors expressing low vs. high Wip1 (n=19 vs. 3), negative vs. high p53 (n=15 vs. 7), low vs. high phospho-p53 (n=2 vs. 20), low vs. high nuclear p38 (n=11 vs. 11), and low vs. high cytoplasmic p38 (n=20 vs. 2). B Advanced-stage tumors expressing low vs. high Wip1 (n=24 vs. 5), negative vs. high p53 (n=18 vs. 11), low vs. high phospho-p53 (n=3 vs. 26), low vs. high nuclear p38 (n=1 vs. 28), and low vs. high cytoplasmic p38 (n=8 vs. 21)